Generation of an induced pluripotent stem cell line (FDCHi008-A) from an infant with chronic intestinal...

Area of Science:

• Gastroenterology
• Stem Cell Biology
• Pediatric Medicine

Background:

• Chronic intestinal pseudo-obstruction (CIPO) is a rare, severe form of gastrointestinal dysmotility.
• It presents as intestinal obstruction without physical blockage.
• Understanding pediatric CIPO pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

• To establish a patient-specific induced pluripotent stem cell (iPSC) line from an infant diagnosed with CIPO.
• To create a novel in vitro model for investigating the mechanisms underlying pediatric CIPO.
• To facilitate research into the pathogenesis of gastrointestinal dysmotility in infants.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were collected from a 4-month-old infant with CIPO.
• Induced pluripotent stem cells (iPSCs) were generated from the collected PBMCs, establishing the FDCHi008-A cell line.
• Characterization of the iPSC line for pluripotency and potential differentiation into gastrointestinal lineages.

Main Results:

• Successfully generated and established the iPSC line FDCHi008-A from a CIPO patient's PBMCs.
• The FDCHi008-A line serves as a unique, patient-specific in vitro model.
• This model is suitable for studying the cellular and molecular basis of pediatric CIPO.

Conclusions:

• The establishment of the FDCHi008-A iPSC line provides a valuable tool for CIPO research.
• This patient-specific model offers new avenues for exploring the pathogenesis of pediatric intestinal pseudo-obstruction.
• Further studies using this model can lead to targeted therapeutic strategies for CIPO.